Tuesday, July 5, 2022

CLINICAL TRIALS DRIVE PROGRESS

Clinical Trials Drive Progress

Only 3 to 6 percent of eligible patients participate in immunotherapy clinical trials. Let’s review some of the top considerations for patients who are exploring their clinical trial options.


No comments:

Post a Comment